Development and head-to-head comparison of machine-learning models to identify patients requiring prostate biopsy

被引:0
作者
Shuanbao Yu
Jin Tao
Biao Dong
Yafeng Fan
Haopeng Du
Haotian Deng
Jinshan Cui
Guodong Hong
Xuepei Zhang
机构
[1] The First Affiliated Hospital of Zhengzhou University,Department of Urology
[2] Key Laboratory of Precision Diagnosis and Treatment for Chronic Kidney Disease in Henan Province,undefined
来源
BMC Urology | / 21卷
关键词
Prostate cancer; Machine learning; Predictive model; Prostate biopsy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 150 条
[1]  
Ferlay J(2015)Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012 Int J Cancer 136 E359-E386
[2]  
Soerjomataram I(2016)Detection of high-grade prostate cancer using a urinary molecular biomarker-based risk score Eur Urol 70 740-748
[3]  
Dikshit R(2013)Influence of imaging and histological factors on prostate cancer detection and localisation on multiparametric MRI: a prospective study Eur Radiol 23 2019-2029
[4]  
Eser S(2015)Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: correlation with whole-mount histopathology Eur Urol 67 569-576
[5]  
Mathers C(2016)Predicting the future—big data, machine learning, and clinical medicine N Engl J Med 375 1216-1219
[6]  
Rebelo M(2019)Use of machine learning to predict early biochemical recurrence after robot-assisted prostatectomy BJU Int 123 51-57
[7]  
Van Neste L(2006)Assessing prostate cancer risk: results from the Prostate Cancer Prevention Trial J Natl Cancer Inst 98 529-534
[8]  
Hendriks RJ(2015)Prostate cancer screening in men aged 50–69 years (STHLM3): a prospective population-based diagnostic study Lancet Oncol 16 1667-1676
[9]  
Dijkstra S(2017)Improving the Rotterdam European randomized study of screening for prostate cancer risk calculator for initial prostate biopsy by incorporating the 2014 International Society of Urological Pathology Gleason Grading and Cribriform growth Eur Urol 72 45-51
[10]  
Trooskens G(2016)Development and external multicenter validation of Chinese Prostate Cancer Consortium prostate cancer risk calculator for initial prostate biopsy Urol Oncol 34 e4161-e4167